Abstract

Carbon dots (CDs) have been widely used as candidates for drug carriers and bio-imaging probes because of their high drug loading capacity and intrinsic fluorescence property, as well as their good biocompatibility. In this study, the potential role of CDs in regulating the aggregation behavior of human islet amyloid polypeptide (hIAPP) was explored for the first time. Five kinds of CDs belonging to three categories, namely polymer dots (PDs-1 and PDs-2), carbon nanodots (CNDs and CQDs), and graphene quantum dots (GQDs), were prepared and characterized. The fibrillation behaviors of hIAPP in the presence of these CDs were monitored by the ThT assay and TEM/AFM imaging, and the cytotoxicity of the systems was tested by the MTT and LDH release assays. Our results showed that the polymer dots and carbon nanodots inhibit hIAPP fibrillation, while the GQDs promoted the formation of hIAPP fibrils. The PDs and GQDs that were nontoxic in INS-1 cells exerted effects leading to decreasing cell death induced by hIAPP through different mechanisms. The inhibitory activity and mechanism of the CDs were closely associated with their structures and surface properties. Our results shed light on a new potential application of CDs in therapeutics.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.